Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06485986

Frontosubthalamic Networks in Parkinson's Disease.

Led by University of Oxford · Updated on 2025-04-02

20

Participants Needed

1

Research Sites

117 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this experimental study with is to understand the underlying mechanisms behind the increase in impulsivity seen in some patients that undergo deep brain stimulation of the subthalamic nucleus for Parkinson's Disease. The main questions it aims to answer are: What are the distributed network effects of deep brain stimulation to the subthalamic nucleus? How does this correlate with increased impulsivity? Can alternative stimulation settings be used to minimize these? Participants will complete decision-making tasks whilst their deep brain stimulation devices are turned on and off with simultaneous magnetoencephalography recordings (a type of non-invasive brain scan that measures brain activity in real-time)

CONDITIONS

Official Title

Frontosubthalamic Networks in Parkinson's Disease.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to give informed consent for participation
  • Male or female aged 18 years or older
  • Diagnosed with Parkinson's Disease and implanted with subthalamic nucleus electrodes for DBS alongside dopamine replacement therapy
  • Diagnosed with or without impulse control disorders since Parkinson's diagnosis
  • Willing and able to sit in the MEG scanner and follow instructions
  • Willing and able to delay morning dopamine replacement therapy dose for up to four hours during the experiment
Not Eligible

You will not qualify if you...

  • Significant language barrier preventing understanding of study purpose or instructions, even with interpreter
  • Presence of other implanted medical devices causing artefacts in MEG recordings
  • History of other neurological disorders
  • Currently enrolled in another neurological disorder clinical trial that could interfere with results
  • Unable to sit still in MEG scanner for the study duration, such as due to chronic pain or osteoarthritis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

John Radcliffe Hospital

Oxford, United Kingdom, OX39DU

Actively Recruiting

Loading map...

Research Team

J

John Eraifej, BSc MBChB MRCS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Frontosubthalamic Networks in Parkinson's Disease. | DecenTrialz